CLOSE
BACK

OUR FUNDS

CLOSE

Harding Loevner International Fund

An International Fund targeting superior risk-adjusted returns through investing in high-quality and durable growing companies at reasonable prices.

November 2023 - Monthly REPORT

November Report

SUMMARY

  • Global share markets roared back in November as inflation pressures eased, raising hopes that interest rates in most major economies would not rise further.
  • Falling interest rate expectations boosted growth stocks, with information technology and industrial company shares performing particularly strongly.
  • The Fund returned 5.0% in November, outperforming the benchmark which returned 4.3%.

PORTFOLIO

Top Holdings (alphabetically)

Alphabet Inc
United States
Communication Services
Alphabet Inc. operates as a holding company. The Company, through its subsidiaries, provides web-based search, advertisements, maps, software applications, mobile operating systems, consumer content, enterprise solutions, commerce, and hardware products.
Amazon.com Inc
United States
Consumer Discretionary
Amazon.com, Inc. is an online retailer that offers a wide range of products. The Company products include books, music, computers, electronics and numerous other products. Amazon offers personalized shopping services, Web-based credit card payment, and direct shipping to customers. Amazon also operates a cloud platform offering services globally.
CME Group Inc
United States
Financials
CME Group Inc. operates a derivatives exchange that trades futures contracts and options on futures, interest rates, stock indexes, foreign exchange, and commodities. The Company brings together buyers and sellers of derivatives products on its trading floors, electronic trading platform, and through privately negotiated transactions that it clears.
Deere & Co
United States
Industrials
Deere & Company manufactures and distributes a range of agricultural, construction, forestry, and commercial and consumer equipment. The Company supplies replacement parts for its own products and for those of other manufacturers. Deere also provides product and parts financing services. Deere and Company extends its services and products worldwide.
Meta Platforms Inc
United States
Communication Services
Meta Platforms, Inc. operates as a social technology company. The Company builds applications and technologies that help people connect, find communities, and grow businesses. Meta Platform is also involved in advertisements, augmented, and virtual reality.
Microsoft Corp
United States
Information Technology
Microsoft Corporation develops, manufactures, licenses, sells, and supports software products. The Company offers operating system software, server application software, business and consumer applications software, software development tools, and Internet and intranet software. Microsoft also develops video game consoles and digital music entertainment devices.
Schneider Electric SE
France
Industrials
Schneider Electric SE manufactures electrical power products. The Company offers car chargers, home security goods, light switches, access control, sensors, valves, circuit breakers, cables, accessories, signaling devices, fuse, motor starters, and voltage transformers. Schneider Electric serves customers worldwide.
Thermo Fisher Scientific Inc
United States
Health Care
Thermo Fisher Scientific, Inc. manufactures scientific instruments, consumables, and chemicals. The Company offers analytical instruments, laboratory equipment, software, services, consumables, reagents, chemicals, and supplies to pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies.
UnitedHealth Group Inc
United States
Health Care
UnitedHealth Group Incorporated owns and manages organized health systems. The Company provides employers products and resources to plan and administer employee benefit programs. UnitedHealth serves customers in the United States.
Vertex Pharmaceuticals Inc
United States
Health Care
Vertex Pharmaceuticals Incorporated discovers, develops, and commercializes pharmaceutical products. The Company develops drugs for the treatment of cystic fibrosis, cancer, inflammatory bowel, autoimmune disease, and neurological disorders. Vertex Pharmaceuticals serves healthcare sector worldwide.

Sector Breakdown

Capitalisation Breakdown

Region Breakdown

PERFORMANCE

PERFORMANCE SINCE STRATEGY INCEPTION

NET PERFORMANCE FOR PERIODS ENDING 30 Nov 20236

Pengana Harding Loevner International Fund Class B

The Class was established in 1 July 2015. From June 2021 Harding Loevner was appointed as the investment manager for the Fund.

1M 1Y 2Y
Since
Harding Loevner
Appointed June 20211
3Y 5Y
Since Fund
Inception
July 20152
Since Strategy
Inception
November 19893
Fund (APIR PCL0026AU)1,2

Managed by Harding Loevner from June 2021
5.0% 12.2% -6.1% 0.4% 2.3% 8.6% 8.5%
Current Strategy (Partial Simulation)4

Harding Loevner Global Equity Strategy
2.8% 9.7% 10.0% 9.1%
Index5 4.3% 13.1% 2.9% 7.1% 9.5% 11.2% 9.9% 7.1%

Swipe horizontally to see all columns

PERFORMANCE SINCE STRATEGY INCEPTION

NET PERFORMANCE SINCE INCEPTION7

COMMENTARY

Market Review

Global share markets rebounded strongly as inflation data eased across major developed economies. This enabled central banks to pause hiking interest rates and investors switched their attention towards lower rates next year. Market sentiment improved further as US-China relations appeared less frosty after Presidents Joe Biden and Xi Jinping met.

All global equity market regions and sectors (except energy) strengthened during November. The month saw a rotation of portfolios into growth stocks as interest rate expectations fell and energy prices dropped further. This particularly boosted the information technology sector, while strength in industrials may be a sign of improving consumer and business sentiment.

Falling oil prices as the US increased output, OPEC+ failed to agree meaningful production cuts and concerns grew about demand from China, weighed on the energy sector. In November stocks fared well across all major markets except China, which again lagged despite an improvement in retail sales and industrial production data.

Portfolio Comment

The Fund outperformed the benchmark during November, driven by its strong relative stock performance, especially in health care, communications services, and Europe more generally. The Fund’s overweight position in health care (which underperformed the broader market at an index level) and weak stock performance in consumer discretionary were the main detractors from relative returns.

Shares of Netherlands-based payment processing firm Adyen recovered from a sell-off in the previous quarter. This followed the company reiterating its long-term strategy and competitive advantage at its 8 November investor day. The company projected that it would deliver annual revenue growth in the low-to-high 20% range through 2026. This validated the Fund’s assessment that Adyen’s technological edge and superior digital payments platform will drive increasing market share in a fast-growing industry. Furthermore, it forecast that from next year it will gradually expand EBITDA margins, which are anticipated to exceed 50% by 2026.

Strong third-quarter earnings results were published by US-based international streaming and production company Netflix and US-based image-sharing and social media platform Pinterest. Both stocks outperformed, driving strong stock performance in the Fund’s communication services holdings.

In the Consumer Staples sector, the Fund holds France-based L’Oréal, which is the world’s largest cosmetics company. It outperformed after the company’s display of its beauty technologies on its capital markets day impressed investors.

The Fund’s stock performance was strongest in Europe, with outperformance particularly strong inside the eurozone. In addition to Adyen, France-based digital automation and energy management group Schneider Electric, and Germany-based multinational software company SAP outperformed upon reporting strong third-quarter earnings results.

Stock performance in the US detracted from relative returns in November. Biopharmaceutical group Vertex Pharmaceutical which focuses on cystic fibrosis treatments underperformed following strong share price gains this year. Meanwhile, energy services business Schlumberger underperformed upon weaker oil prices.


As we move into the final month of the calendar year we will look to deliver a ‘year in review’ in early 2024. Please let us know any questions you would like us to cover, either specific to the sector, Portfolio, or any portfolio holdings below.


PROFILE

STATISTICAL DATA2

PORTFOLIO SUMMARY
VOLATILITY8
11.1%
NUMBER OF STOCKS
63
BETA9
0.89

FEATURES

  • APIR CODE PCL0026AU
  • REDEMPTION PRICEA$ 0.9023
  • FEES * Management Fee: 0.974%
    Performance Fee: Nil
  • Minimum initial investment $10,000
  • FUM AT MONTH END A$ 42.29m
  • STRATEGY INCEPTION DATE 1 December 1989
  • BenchmarkMSCI All Country World Total Return Index (net) in $A

Fund Managers

Peter Baughan

Portfolio Manager

Jingyi Li

Portfolio Manager

Rick Schmidt

Portfolio Manager

Description

An International Fund targeting superior risk-adjusted returns through investing in high-quality and durable growing companies at reasonable prices.

The Pengana Harding Loevner International Fund invests in high-quality, growing companies identified through fundamental research with a long-term, global perspective.

Pengana has appointed Harding Loevner to managed the Fund.  Harding Loevner is a New Jersey-based global equity fund manager formed in 1989 with over US$86billion in Assets under Management.

Harding Loevner’ analysts search the world for companies that meet their high quality and durable growth criteria, conduct fundamental research, then value and rate their stocks to make them available to PMs for investment.

EXPLORE OUR FUNDS

Harding Loevner International Fund
Harding Loevner International Fund
Axiom International Fund
Axiom International Fund
Axiom International Fund (Hedged)
Axiom International Fund (Hedged)
Australian Equities Fund
Australian Equities Fund
High Conviction Property Securities Fund
High Conviction Property Securities Fund
Global Small Companies Fund
Global Small Companies Fund
WHEB Sustainable Impact Fund
WHEB Sustainable Impact Fund
Emerging Companies Fund
Emerging Companies Fund
High Conviction Equities Fund
High Conviction Equities Fund
Pengana International Equities Limited (ASX: PIA)
Pengana International Equities Limited (ASX: PIA)
Private Equity Trust (ASX: PE1)
Private Equity Trust (ASX: PE1)
Alpha Israel Fund
Alpha Israel Fund
Pengana Diversified Private Credit Fund
Pengana Diversified Private Credit Fund

1. Harding Loevner was appointed fund manager as of 10 May 2021. June 2021 represents the first full month of Harding Loevner managing the Fund.
2. Class B Inception date 1 July 2015. Figures shown are calculated from the continuous performance of both the current and previous strategies. For performance see row labelled Fund (APIR PCL0026AU) in the table above which is the continuous performance of both the current and previous (shaded) strategies.
3. Harding Loevner Global Equity Strategy inception 1 Dec 1989
4. Prior to June 2021, the Harding Loevner Global Equity Strategy performance (labelled ‘Current Strategy (Partial Simulation)’ and shown in the shaded area) includes the strategy performance simulated by Pengana from the monthly gross returns of the Harding Loevner Global Equity strategy. This simulation was done by: 1) the conversion of US-denominated gross returns to AUD, 2) applying the fee structure of Class B. From June 2021 the strategy performance is the performance of the Pengana Harding Loevner International Fund Class B.
5. MSCI All Country World Total Return Index in AUD.
6. Performance for periods greater than 12 months are annualised. Net performance figures are shown after all fees and expenses and assume reinvestment of distributions. No allowance has been made for buy/sell spreads. Please refer to the PDS for information regarding risks. Past performance is not a reliable indicator of future performance, the value of investments can go up and down.
7. The Harding Loevner Global Equity Strategy performance (shown in the shaded area in the chart, and in the performance table as row labeled ‘Harding Loevner Global Equity Strategy) has been simulated by Pengana from the monthly gross returns of the Harding Loevner Global Equity strategy. This simulation was done by: 1) the conversion of US-denominated gross returns to AUD, 2) applying the fee structure of the stated class. Strategy Inception 30 November 1989.
8. Annualised standard deviation since inception.
9. Relative to MSCI All Country World Total Return Index in AUD
* For further information regarding fees please see the PDS available on our website.